Products

📄Product Profile & Long Information Guide Product Name: Estrabet Gel (Estradiol 0.06% w/w Hemihydrate Topical Gel) 1. Clinical Indications & Usage (Why It Is Used) Moderate to Severe Vasomotor Symptoms: Rapidly eliminates distressing menopausal signs like hot flashes, sudden night sweats, and unexpected body temperature spikes. Vulvovaginal Atrophy Management: Restores natural moisture and tissue elasticity to the intimate areas, mitigating dryness, painful friction, burning sensations, and chronic discomfort linked to postmenopausal transitions. Hypogonadism or Ovarian Failure: Used under medical guidance to supplement missing sex hormones when natural ovarian production is diminished due to primary failure or clinical removals. 2. Mechanism of Action (How Estrabet Gel Works) Transdermal Absorption Flow: When rubbed onto dry skin, the gel dries quickly, forming a microscopic lipid layer that steadily passes through the skin tissue directly into your bloodstream. Receptor Synchronization: Once absorbed, it targets estrogen receptors located across tissues (bones, cardiovascular endpoints, brain, and mucous linings), safely restoring systemic equilibrium and alleviating clinical postmenopausal conditions without loading your stomach or liver. 3. Administration and Consumer Dosing Guide Strict Prohibitions: NEVER apply this gel anywhere near your breasts, face, or intimate vulvovaginal areas. Never ingest it orally. Application Method: Apply the prescribed amount of gel daily onto entirely clean, completely dry, unbroken skin—ideally across your shoulders, outer arms, or inner thighs. Absorption Timing: Let the gel dry fully for at least 3 to 5 minutes before dressing. Wash your hands thoroughly with soap right after application so you do not accidentally transfer estrogen residue to kids, family members, or household pets. ⚠️ Safety, Side Effects, and Monitoring Guidelines Cardiovascular & Tissue Warning: Long-term unmonitored estrogen supplementation can influence risks associated with localized blood clot formations, severe strokes, or tissue thickening within the womb lining if used inappropriately. Common Skin & Body Adjustments: Mild irritation or temporary redness at the application site, breast tenderness, mild headaches, breakthrough spot bleeding, mood fluctuations, or fluid retention. Medical Surveillance: Regular baseline and annual follow-ups with your physician or gynecologist (including breast examinations and blood pressure checks) are necessary to guarantee optimal ongoing health safety. 📦 Storage and Handling Specifications Temperature Restrictions: Store the gel canister or tube upright in a cool, clean environment consistently kept below 30°C (86°F). Moisture Safeguards: Keep it safely packed away from heavy bathroom humidity, direct sunlight, and heat sources. Ensure the cap is tightly fastened after every single pump or application. Keep strictly safe from children and pets. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: Estrabet Gel is a specialized prescription hormonal therapy that must only be initiated and utilized under the direct guidance and continuous clinical monitoring of a registered healthcare specialist or gynecologist. This profile serves strictly for educational research, international inquiry, and informational purposes. Estrabet Gel is completely contraindicated for use during pregnancy or breastfeeding due to significant fetal risks. Effective precautions must be taken to prevent skin-to-skin contact of the application site with infants or male partners. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: International Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 https://wa.me/919673008130

Dulata 30mg Tablet: Comprehensive Patient & Consumer Guide 1. Clinical Indications & Usage Major Depressive Disorder (MDD): Deployed systematically to stabilize and enhance mood, minimize persistent feelings of sadness, alleviate emotional fatigue, and assist individuals in reclaiming functional daily routines. Generalized Anxiety Disorder (GAD): Prescribed to manage chronic, excessive, and uncontrollable worry or nervous tension associated with daily life events. Fibromyalgia & Chronic Musculoskeletal Pain: Used as a comprehensive long-term management strategy to alleviate deep tissue discomfort, widespread muscle pain, persistent osteoarthritis aches, and chronic lower back pain. 2. Mechanism of Action: How Dulata Works Dual Reuptake Inhibition: Dulata belongs to a class of drugs known as Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs). It works by safely restricting the reabsorption (reuptake) of two key chemical messengers in the brain: serotonin and norepinephrine. Sustaining Neurotransmitter Levels: By blocking their reuptake pathways, the tablet effectively leaves a higher concentration of active serotonin and norepinephrine available in the synaptic spaces between neurons. 3. Administration and Dosing Guide Method of Intake: Dulata 30mg is an oral tablet formulation. It must be swallowed whole with a full glass of water. It should never be chewed, crushed, dissolved in liquids, or broken in half, as doing so damages the specialized protective coating and can lead to immediate, unsafe release of the drug. Food Flexibility: The tablet can be consumed consistently either with or without food. Taking it with a light meal can be highly beneficial for patients who experience mild stomach issues during the initial weeks of therapy. Standard Scheduling: The standard therapeutic baseline typically ranges from 30mg to 60mg taken once daily, as precisely determined by your supervising doctor. It is highly recommended to take your dose at the exact same time every day to keep a stable balance of the medication inside your system. Never double a dose or abruptly halt consumption without explicitly speaking to your doctor first. 4. Safety, Side Effects, and Monitoring Discontinuation Care: Never stop taking this medication abruptly. Halting it suddenly can induce discontinuation symptoms such as dizziness, sensory tingles, vivid dreams, or nausea. Your healthcare provider will supply a gradual tapering schedule if the drug needs to be discontinued. Blood Pressure Management: SNRIs can occasionally cause mild to moderate increases in baseline blood pressure. Patients should regularly measure their blood pressure at home or during standard doctor visits. Common Side Effects: During the first one to two weeks of beginning treatment, some individuals may encounter mild, temporary adaptations. These can include: Dry mouth and mild changes in taste Nausea, decreased appetite, or minor constipation Increased sweating or occasional hot flashes Mild drowsiness, daytime fatigue, or trouble falling asleep initially Dizziness when standing up too quickly 5. Storage and Handling Specifications Temperature Frame: Store Dulata 30mg tablets in a stable, cool environment consistently below 30°C (86°F). Safety Safeguards: Keep this medication stored on a high shelf or inside a locked cabinet, strictly out of sight and reach of children and domestic pets. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer:Dulata 30mg Tablet is a specialized, highly regulated prescription medicine that must exclusively be taken under the direct clinical advice, authorization, and ongoing monitoring of a registered medical practitioner. The detailed information presented here is compiled solely for educational, historical, and consumer research purposes and under no circumstance replaces professional medical diagnosis, individualized treatment plans, or clinical advice. Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Entity Type: International Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 https://wa.me/919673008130

Comprehensive Product Guide: Understanding Tadanova-D Tab 1. Clinical Indications & Active Components Erectile Dysfunction (ED): The inability to attain or sustain an erection firm enough for satisfactory sexual activity. Premature Ejaculation (PE): The tendency to ejaculate sooner than desired, often leading to distress or dissatisfaction. Tadalafil: A celebrated, long-lasting Phosphodiesterase Type 5 (PDE5) inhibitor that addresses structural blood flow. Dapoxetine: A fast-acting, selective serotonin reuptake inhibitor (SSRI) specifically developed to delay the ejaculation reflex and boost personal control. 2. Molecular Mechanism of Action: How It Works Extending Timing and Control (Dapoxetine Pathway): Ejaculation is largely regulated by the central nervous system. Dapoxetine inhibits the reuptake of serotonin at the neuronal synapses. By increasing serotonin activity within the nervous system, it extends the time it takes to ejaculate and significantly enhances individual control over the climax reflex. Sustaining Hardness (Tadalafil Pathway): During physical arousal, nitric oxide is released into the erectile tissue, stimulating an enzyme that produces cyclic Guanosine Monophosphate (cGMP). This chemical relaxes the smooth muscle walls, allowing a rapid influx of blood. The PDE5 enzyme normally breaks down cGMP to end an erection. Tadalafil blocks this enzyme, keeping cGMP levels elevated, which maintains robust blood flow for an extended period. 3. Administration and Optimal Dosing Guide How to Take: Swallowed whole with a glass of plain water. Do not break, crush, chew, or dissolve the tablet.Timing: It should be taken roughly 1 to 3 hours before any anticipated physical intimacy. Food Considerations: Tadanova-D can be taken with or without food. However, avoiding exceptionally heavy, high-fat meals is highly recommended, as large amounts of fat can delay the absorption of Dapoxetine, reducing its speed of action. 4. Storage and Handling Framework Temperature: Store the tablets consistently below 30°C (86°F) in a cool, well-ventilated space. Moisture Protection: Avoid keeping the medicine in high-humidity areas like bathroom medicine cabinets. Keep them sealed within their original blister packaging. Light Shielding: Keep the pack inside its outer box away from direct solar radiation or heavy UV exposure. Safety: Store high on shelves or in locked compartments completely out of reach of children and domestic pets. 5. Essential Safety, Side Effects, and Monitoring Potential Side Effects: Some individuals may experience temporary mild adjustments as their bodies get used to the medication. Common symptoms include mild headaches, facial flushing, nasal congestion, mild dizziness, nausea, backaches, or indigestion. Important Warning (Priapism): In extremely rare instances, a prolonged erection lasting over 4 hours may occur. If this happens, immediate medical attention must be sought to avoid permanent tissue damage. Dizziness and Focus: Because Dapoxetine can cause brief drops in blood pressure resulting in dizziness, individuals should avoid driving or operating heavy machinery immediately after consuming the tablet. PRESCRIPTION MEDICINE IS: YES Clinical Disclaimer: Tadanova-D Tab is a high-potency prescription medication that should only be consumed under the strict supervision and authorization of a registered medical specialist. It is not an over-the-counter drug. This profile is intended purely for consumer awareness and educational research purposes. Individuals with severe cardiovascular conditions, uncontrolled blood pressure, or those taking nitrate medications must completely avoid this drug. Side effects must be monitored closely by a healthcare professional. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] 🌐Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Entity Type: International Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 https://wa.me/919673008130

Extensive Product Profile: Understanding Celzar 200mg Injection Celzar 200mg Injection contains Gemcitabine, an advanced nucleoside metabolic inhibitor. It is globally recognized as a cornerstone antineoplastic therapy prescribed by oncologists worldwide to target, manage, and treat various aggressive forms of solid tumor malignancies. 1. Clinical Indications & Usage Metastatic Breast Cancer: Administered in combination with Paclitaxel as a first-line intervention for patients with metastatic breast cancer after failure of prior anthracycline-based adjuvant chemotherapy. Advanced Non-Small Cell Lung Cancer (NSCLC): Utilized in combination with Cisplatin as first-line treatment for patients with inoperable, locally advanced, or metastatic NSCLC. Ovarian Cancer: Deployed in combination with Carboplatin for the treatment of patients with advanced epithelial ovarian cancer that has recurred at least 6 months after completion of platinum-based therapy. 2. Mechanism of Action: How Celzar Works DNA Synthesis Inhibition: The diphosphate metabolite inhibits ribonucleotide reductase, reducing the cellular pool of essential deoxyribonucleoside triphosphates required for DNA repair and replication. Enzyme Mimicry: As a nucleoside analogue, Gemcitabine is metabolized intracellularly by nucleoside kinases into active diphosphate (dFdCDP) and triphosphate (dFdCTP) nucleosides. 3. Administration and Dosing Guide Administration Route: Intravenous (IV) infusion only. It must be prepared by clinical personnel and infused over a strictly monitored period (typically 30 minutes). Altering infusion duration beyond recommended limits can spike toxicities. Clinical Monitoring: Routine baseline assessments and pre-dose evaluations of liver function, kidney function, and absolute blood counts are mandatory before initiating every individual treatment cycle. 4. Safety, Side Effects, and Monitoring Bone Marrow Suppression: Severe myelosuppression (anemia, leukopenia, and thrombocytopenia) is the primary dose-limiting toxicity. Absolute neutrophil counts (ANC) and platelet numbers must be reviewed prior to every infusion. Pulmonary Toxicity: Serious cases of respiratory adverse drug reactions, such as pulmonary edema, interstitial pneumonitis, or Adult Respiratory Distress Syndrome (ARDS), have been reported. Development of a new cough or unexplained dyspnea warrants immediate suspension of the drug. Common Side Effects: Nausea, vomiting, elevated liver transaminases (ALT/AST), transient proteinuria, mild hematuria, alopecia, flu-like symptoms (fever, chills, headache), rash, and peripheral edema. 5. Storage and Handling Specifications Storage Environment: Prior to reconstitution, the dry powder vial must be stored at a stable room temperature below 30°C (86°F). Precautions: Do not freeze the unreconstituted or reconstituted product, as crystallization can occur. Store within the original outer box to block direct UV light or heavy ambient moisture degradation. Keep strictly safe from children and pets. PRESCRIPTION MEDICINE IS : YES Disclaimer: Celzar 200mg Injection is a specialized prescription oncology drug that must only be administered under the direct clinical guidance and physical supervision of a registered medical oncologist in an authorized treatment setting. This information is meant strictly for educational research purposes. Celzar is highly toxic to fetal development; strict non-hormonal contraceptive methods must be pursued during therapy, and breastfeeding is completely contraindicated. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Entity Type: International Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗https://wa.me/919673008130

Global Patient & Clinician Guide: Celvestrant 250 mg PFS Injection Celvestrant 250 mg Pre-Filled Syringe (PFS) contains Fulvestrant, an advanced, selective antineoplastic estrogen receptor antagonist. Manufactured to meet rigorous global standards by Celon Laboratories Ltd., it serves as a critical endocrine (hormone) therapy used worldwide to manage advanced, hormone-dependent malignancies. 1. Clinical Indications & Usage Hormone Receptor-Positive (HR+) Advanced Breast Cancer: Used as a single agent (monotherapy) to treat postmenopausal women with hormone receptor-positive, locally advanced, or metastatic breast cancer that has progressed following prior anti-estrogen therapy. HR+/HER2-Negative Metastatic Breast Cancer (Combination Therapy): Indicated for use in combination with CDK4/6 inhibitors (such as palbociclib, ribociclib, or abemaciclib) or other targeted anti-cancer agents for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in women. 2. Mechanism of Action: How Celvestrant Works Estrogen Receptor Binding: Fulvestrant functions as a competitive estrogen receptor antagonist, directly attaching to estrogen receptors inside the breast cancer cells with high affinity. Receptor Down-regulation: Beyond simply blocking the receptor, it alters the structural shape of the receptor, causing the cell to degrade it. This process down-regulates (reduces the overall number of) available estrogen receptors over time. Halting Proliferation: By depriving the tumor cells of essential estrogenic signaling pathways, Celvestrant prevents the transcription of estrogen-dependent genes, effectively slowing or stopping the growth and spread of the cancer. 3. Administration and Dosing Guide Administration Route: Celvestrant is strictly formulated for intramuscular (IM) injection into the gluteal muscle (buttock). It must never be given intravenously, subcutaneously, or taken orally. Administration Protocol: The solution must be injected slowly over 1 to 2 minutes by a qualified medical professional. A standard full dose is typically split into two separate 250 mg pre-filled syringes (one slow injection into each buttock). Standard Schedule: The standard adult dosing regimen begins with a loading phase to achieve steady therapeutic levels quickly, followed by maintenance dosing: Day 1: Initial 500 mg dose (two 250 mg injections). Day 15: Second 500 mg loading dose. Day 29: Third 500 mg dose. Maintenance Phase: 500 mg administered once every 28 days thereafter. 4. Safety, Side Effects, and Clinical Monitoring Injection Site Reactions: Due to the volume and intramuscular nature of the medication, localized pain, swelling, transient inflammation, sciatica, or bruising at the injection site are among the most common physical reactions. Bleeding Risks: Caution must be exercised if a patient has an underlying bleeding disorder or is taking systemic anticoagulants (blood thinners), due to the physical risk of deep muscular hematoma from the intramuscular injection. Common Side Effects: Hot flashes, generalized fatigue (weakness), nausea, vomiting, decreased appetite, joint and bone pain (musculoskeletal pain), back pain, headache, diarrhea, constipation, urinary tract infections, and skin rashes. 5. Storage and Handling Specifications Environmental Protection: Keep the pre-filled syringes securely enclosed in their original manufacturer carton to protect the solution from direct light exposure and excessive moisture. Temperature Management: Celvestrant 250 mg PFS must be stored in a secure refrigerator between 2°C and 8°C (36°F to 46°F). It must never be allowed to freeze. Safety Precaution: Store strictly out of sight and reach of children and domestic animals. Clinical Disclaimer: This comprehensive profile is compiled strictly for educational, scientific research, and informational purposes. Celvestrant 250 mg PFS Injection is a highly specialized oncology prescription medicine. It must be administered exclusively by a trained healthcare professional (doctor or nurse) in a clinical setting. Self-administration is strictly prohibited. PRESCRIPTION MEDICINE: YES 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celplat 50mg Injection Celplat 50mg Injection contains Cisplatin, an advanced, gold-standard platinum-based alkylating antineoplastic agent. Formulated to the highest global pharmaceutical benchmarks by Celon Laboratories Ltd., this high-strength cytotoxic injection is widely prescribed by oncology specialists globally to treat aggressive, advanced solid tumors and mutation-specific malignancies. 1. Clinical Indications & Usage Advanced Testicular Cancer: Deployed as established first-line combination therapy for patients with advanced or metastatic testicular germ cell tumors who have already undergone appropriate surgical resection or radiation. Advanced Ovarian Cancer: Indicated as primary combination therapy with other approved chemotherapeutic agents, or as single-agent systemic treatment, for patients with advanced or recurrent ovarian malignancies who have previously received platinum-based therapies. Squamous Cell Head and Neck Cancers: Administered as a potent radiosensitizer alongside radiotherapy or systemic combinations to combat advanced epithelial tumors of the head, neck, nasopharynx, and oral cavity. 2. Mechanism of Action: How Celplat Works Aquation and Activation: Once inside the low-chloride environment of the cancer cell cytoplasm, the Cisplatin molecule undergoes activation (aquation), losing its chloride leaves to become a highly reactive, positively charged platinum complex. DNA Cross-Linking: The activated platinum complex binds directly to the cellular genetic blueprint, forming strong covalent bonds primarily at the N-7 position of guanine and adenine bases. This results in tight intra-strand and inter-strand DNA cross-links. Replication Roadblock: These heavy structural cross-links fundamentally warp the double-helix geometry of the DNA. This creates an impassable roadblock that halts replication forks, stops RNA transcription, and completely suppresses further DNA synthesis. 3. Administration and Dosing Guide Administration Route: Celplat 50mg is formulated strictly for intravenous (IV) infusion. It must be diluted in an appropriate volume of sodium chloride-containing sterile fluids and administered via a secure intravenous line. It is highly unsafe for direct push and must never be self-administered. Intensive Hydration Framework: To protect the kidneys, patients must undergo intensive intravenous pre-hydration with 1 to 2 liters of fluid infused over 8 to 12 hours before receiving the drug. Adequate hydration and high urine output must be strictly maintained for 24 hours post-infusion, often accompanied by mannitol or furosemide-induced diuresis. 4. Safety, Side Effects, and Monitoring Severe Nephrotoxicity (Kidney Damage): Dose-related and cumulative renal tubular damage is the major dose-limiting risk of Cisplatin. Comprehensive pre-dose kidney function profiles (Blood Urea Nitrogen [BUN], Serum Creatinine, and Creatinine Clearance) alongside serum electrolyte checks (Magnesium, Potassium, Calcium) are mandatory before starting every treatment cycle. Severe Ototoxicity (Hearing Damage): This medication can cause significant inner ear toxicity, manifesting as severe tinnitus (ringing in the ears), high-frequency hearing loss (4,000 to 8,000 Hz range), or occasional deafness. Audiometric testing should be performed at baseline and before every subsequent dose. 5. Storage and Handling Specifications Temperature Frame: Store Celplat 50mg vials at controlled room temperature between 15°C to 25°C (59°F to 77°F). Do not refrigerate or freeze, as low temperatures will cause the active platinum compound to precipitate out of the solution. Environmental Safeguards: Keep the vials sealed securely inside their original manufacturer packaging carton to shield the medicine from direct UV light exposure. Handle with strict cytotoxic precautions, using appropriate protective equipment, and keep entirely out of reach of children. Prescription Medicine: Yes Clinical Disclaimer: This profile is compiled strictly for informational, educational, and international sourcing transparency. Celplat 50mg Injection is a specialized oncology drug available exclusively under valid clinical prescription. It must be prepared, handled, and administered solely under the direct guidance of a registered oncology specialist in a qualified hospital or clinical infusion environment. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celplat 10mg Injection Celplat 10mg Injection contains Cisplatin, an advanced, gold-standard platinum-based alkylating antineoplastic agent. Formulated to the highest global pharmaceutical standards by Celon Laboratories Ltd., this specialized chemotherapy agent is widely used by oncologists worldwide to treat and manage aggressive solid tumors and mutation-specific malignancies. 1. Clinical Indications & Usage Advanced Testicular Cancer: Used in highly effective combination regimens for patients with advanced testicular tumors who have already undergone appropriate surgical or radiotherapeutic interventions. Advanced Ovarian Cancer: Indicated as combination therapy with other approved chemotherapeutic agents or as a single agent for patients with advanced ovarian tumors who have previously received platinum-based or systemic therapies. Advanced Bladder Cancer: Deployed as a single agent or combination framework for patients with locally advanced or metastatic bladder cancer who are no longer candidates for localized surgery or radiotherapy. Head and Neck Epithelial Tumors: Administered alongside radiotherapy or systemic regimens to combat advanced squamous cell carcinomas of the head and neck. 2. Mechanism of Action: How Celplat Works DNA Cross-Linking: Once inside the cytoplasm, the active Cisplatin molecule sheds its chloride ions and binds directly to the cellular genetic blueprint. It hooks onto guanine and adenine bases, creating tight intra-strand and inter-strand DNA cross-links. Replication Roadblock: These heavy platinum cross-links fundamentally warp the double-helix structure of the DNA. This creates an unpassable block that stops replication forks and suppresses DNA synthesis. Apoptosis Induction: Because rapidly dividing cancer cells cannot repair these severe, platinum-induced structural defects, the cellular check-points trigger a distress cascade. This forces the damaged cancer cells into programmed cell death (apoptosis), halting tumor growth. 3. Administration and Dosing Guide Administration Route: Celplat 10mg is formulated strictly for intravenous (IV) infusion. It must be diluted in appropriate sterile saline lines and administered by a clinical team. It is highly unsafe for direct push and must never be self-administered. Hydration Framework: To protect kidney health, patients must receive intensive intravenous hydration with fluids (often containing mannitol) for 8 to 12 hours before the infusion, and maintain high fluid volume and urine output for 24 hours post-treatment. 4. Safety, Side Effects, and Monitoring Severe Nephrotoxicity (Kidney Damage): Cumulative and dose-related renal tubular damage is a major dose-limiting risk. Comprehensive baseline and pre-dose kidney function profiles (Blood Urea Nitrogen, Serum Creatinine, and Creatinine Clearance) are mandatory before every cycle. Ototoxicity (Hearing Impairment): This medication can cause significant inner ear damage, resulting in severe tinnitus (ringing in the ears), high-frequency hearing loss, or occasional deafness. Pre-treatment and periodic audiometric testing are highly recommended . Bone Marrow Suppression: It temporarily lowers the production of red blood cells, infection-fighting white blood cells, and platelets, increasing the risks of anemia, infections, and bleeding. Baseline and weekly Complete Blood Counts (CBC) are required. 5. Storage and Handling Specifications Temperature Frame: Store Celplat 10mg vials at controlled room temperature between 15°C to 25°C (59°F to 77°F). Do not refrigerate or freeze, as low temperatures will cause the platinum compound to precipitate out of the solution. Environmental Safeguards: Keep the vials sealed securely inside their original manufacturer packaging. Protect the medicine from direct UV light exposure. Handle with strict cytotoxic precautions and keep entirely out of reach of children. Prescription Medicine: Yes Clinical Disclaimer:This profile is compiled strictly for informational, educational, and international sourcing transparency. Celplat 10mg Injection is a specialized oncology drug available exclusively under valid clinical prescription. It must be prepared, handled, and administered solely under the direct guidance of a registered oncology specialist in a qualified clinical environment 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celostatin LAR 30mg Injection Celostatin LAR 30mg contains Octreotide Acetate, an advanced, long-acting synthetic octapeptide that mimics natural somatostatin. Developed under stringent international quality controls by Celon Laboratories Ltd., this specialized Long-Acting Release (LAR) injection is prescribed globally by endocrinologists and oncologists to manage neuroendocrine tumors, growth hormone disorders, and specific gastrointestinal complications. 1. Clinical Indications & Usage Acromegaly: Used for long-term maintenance therapy in adult patients who have responded adequately to or are stabilized on immediate-release subcutaneous octreotide. It helps normalize excess growth hormone (GH) and Insulin-like Growth Factor-1 (IGF-1) levels when surgical resection or radiotherapy is inappropriate or ineffective. Severe Diarrhea and Flushing associated with Metastatic Carcinoid Tumors: Deployed for the symptomatic control of severe watery diarrhea and intense skin flushing episodes linked to metastatic neuroendocrine carcinoid syndrome. Vasoactive Intestinal Peptide-Secreting Tumors (VIPomas): Indicated for the management of profuse, watery diarrhea and associated electrolyte imbalances caused by VIP-secreting pancreatic adenomas. Gastro-Esophageal Variceal Bleeding: Utilized to control acute hemorrhage and prevent re-bleeding from ruptured esophageal varices in patients with chronic liver disease or cirrhosis. 2. Mechanism of Action: How Celostatin LAR Works Somatostatin Receptor Agonism: It binds selectively and with higher potency than natural somatostatin to specific somatostatin receptors (primarily SSTR2 and SSTR5) located throughout the pituitary gland and gastrointestinal tract. Hormonal Suppression: This receptor binding strongly suppresses the excessive secretion of anterior pituitary hormones, effectively reducing circulating levels of growth hormone (GH) and thyroid-stimulating hormone (TSH). Splanchnic Vasoconstriction: To combat variceal bleeding, the active drug induces selective constriction (narrowing) of the splanchnic blood vessels. This safely limits blood inflow to the portal vein system, reducing pressure and halting active hemorrhage in the food pipe. 3. Administration and Dosing Guide Professional Administration: The injection must be prepared and delivered solely by a trained healthcare professional. It is packaged as a comprehensive kit containing a vial of octreotide microspheres, a prefilled vehicle syringe, a vial adapter, and a specialized administration needle. Standard Schedule: For acromegaly and neuroendocrine tumors, the standard clinical starting dosage is 20mg or 30mg administered once every 4 weeks (28 days) for long-term management. Dosages are adjusted symmetrically by the specialist based on therapeutic hormone levels and clinical symptom response. 4. Safety, Side Effects, and Monitoring Gallbladder and Liver Alterations: Long-term utilization inhibits gallbladder contractility and decreases bile secretion, which frequently leads to cholelithiasis (gallstone formation) or biliary sludge. Periodic ultrasound examinations of the gallbladder are clinically advised. Glucose Regulation Instability: Because octreotide suppresses the release of both insulin and glucagon, it can cause unpredictable shifts in blood sugar levels, resulting in either hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar). Regular blood glucose monitoring is mandatory, especially for diabetic patients. 5. Storage and Handling Specifications Cold Chain Logistics: Store Celostatin LAR 30mg kits under strict refrigeration between 2°C to 8°C (36°F to 46°F). Do not freeze. Environmental Safeguards: Keep the kit sealed within its original manufacturer carton box to shield the light-sensitive components from direct UV light exposure. Prior to administration, the kit may be allowed to reach room temperature for roughly 30 to 60 minutes to minimize injection site discomfort, but it must be injected immediately after reconstitution. Keep entirely out of reach of children. Prescription Medicine: Yes Clinical Disclaimer: This profile is compiled strictly for informational, commercial educational research, and global sourcing transparency. Celostatin LAR 30mg Injection is a controlled, high-specialty prescription drug. It must be dispensed, reconstituted, and administered exclusively under the direct supervision of a registered endocrinologist, oncologist, or qualified gastroenterology clinician. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celomide 25mg Capsule Celomide 25mg Capsule contains Lenalidomide, a highly potent small-molecule immunomodulatory agent (IMiD) with powerful anti-angiogenic and direct anti-cancer activities. Formulated under strict international pharmaceutical regulatory benchmarks by Celon Laboratories Ltd., this oral targeted therapeutic option is widely utilized by oncologists globally to manage aggressive plasma cell dyscrasias and complex bone marrow disorders. 1. Clinical Indications & Usage Multiple Myeloma (MM): Prescribed in combination with dexamethasone or as part of highly effective triplet chemotherapy combinations for adult patients with newly diagnosed or relapsed/refractory multiple myeloma. The 25mg capsule typically serves as the standard starting therapeutic dose for the active phase of 28-day treatment cycles. Myelodysplastic Syndromes (MDS): Deployed to manage transfusion-dependent anemia in patients with low- to intermediate-1-risk MDS associated with a cytogenetic anomaly known as the deletion 5q (del 5q) chromosomal defect. Mantle Cell Lymphoma (MCL): Authorized for adult patients with mantle cell lymphoma whose disease has returned, relapsed, or progressed following at least one prior intensive systemic treatment (typically including a proteasome inhibitor like bortezomib). 2. Mechanism of Action: How Celomide Works Cereblon-Mediated Degradation: The drug binds directly to Cereblon (CRBN), a substrate adapter within the intracellular E3 ubiquitin ligase enzyme network. This structural binding forces the rapid degradation of essential lymphoid transcription proteins (Ikaros and Aiolos). Immune System Modulation: By shifting these cellular pathways, Celomide generates an aggressive immune up-regulation. It dramatically triggers the activation and proliferation of the patient's native T-cells and Natural Killer (NK) cells, vastly optimizing the body's natural baseline capability to clear floating tumor populations. Direct Apoptosis Induction: It induces direct cell-cycle arrest in sensitive multiple myeloma and lymphoma cells, stopping replication and driving mutated lines into rapid programmed cell death. 3. Administration and Dosing Guide Administration Route: Celomide 25mg is strictly an oral capsule formulation. The capsule must be swallowed whole with a glass of water at the exact same time every day. It should never be chewed, crushed, split, or opened. Caregivers must avoid direct skin contact or inhalation exposure to the powder contents of damaged capsules. Cyclical Treatment Schedules: For multiple myeloma and lymphoma, the conventional starting regimen involves taking a 25mg capsule once daily on Days 1 through 21 of repeated 28-day treatment cycles, followed by a mandatory 7-day rest window (Days 22–28) to facilitate bone marrow recovery. Dosing adjustments are strictly managed by the treating oncologist. 4. Safety, Side Effects, and Monitoring Severe Bone Marrow Suppression: This medication frequently induces substantial cytopenias. This includes severe neutropenia (profound drop in white blood cells, spiking infection risks) and thrombocytopenia (low platelet counts, raising the risk of bleeding and bruising). Weekly or monthly Complete Blood Counts (CBC) are mandatory. Thromboembolic Hazards: There is an escalated risk of developing dangerous blood clots, including Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), or arterial blockages (stroke/myocardial infarction). Prophylactic blood thinners are routinely co-prescribed. Common Side Effects: Chronic fatigue, diarrhea or constipation, muscle cramps, localized skin rashes, generalized itching, nausea, headache, dizziness, and peripheral edema (fluid retention in the limbs). 5. Storage and Handling Specifications Climate Parameters: Store Celomide 25mg capsules safely below 30°C (86°F) in a dry, dark, temperature-controlled environment. Protective Shields: Keep capsules sealed tightly inside their original manufacturer packaging. Protect the medication from high ambient humidity, ambient moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. Prescription Medicine: Yes Clinical Disclaimer: This profile is compiled strictly for informational, educational, and international sourcing transparency. Celomide 25mg Capsule is a highly restricted, specialized oncology drug available exclusively under valid medical prescription. It must be managed, dispensed, and utilized solely under the direct guidance of a registered oncology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celomide 10mg Capsule Celomide 10mg Capsule contains Lenalidomide, a structural analogue of thalidomide classified as a highly effective immunomodulatory drug (IMiD). Developed under stringent global quality benchmarks by Celon Laboratories Ltd., this oral targeted therapeutic agent plays a vital role in international oncology and hematology lines of care for managing specific plasma cell variants and bone marrow cancers. 1. Clinical Indications & Usage Multiple Myeloma (MM): Utilized either as initial induction therapy or for relapsed/refractory cases, typically combined with dexamethasone or integrated into cutting-edge triplet chemotherapy protocols. The 10mg configuration is frequently utilized for strategic maintenance cycles or individualized dose-titration phases. Myelodysplastic Syndromes (MDS): Indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a cytogenetic deletion 5q (del 5q) chromosomal mutation. Mantle Cell Lymphoma (MCL): Administered to patients with mantle cell lymphoma whose disease has progressed, relapsed, or failed to respond after at least one prior intensive systemic treatment line. 2. Mechanism of Action: How Celomide Works Cereblon Complex Binding: Celomide targets and binds directly to Cereblon (CRBN), a vital part of the intracellular E3 ubiquitin ligase enzyme network. This binding prompts the selective degradation of lymphoid-specific transcription proteins (Ikaros and Aiolos). Immune System Modulation: This molecular shift stimulates a strong immune up-regulation. It dramatically enhances the activation and proliferation of the patient's native T-cells and Natural Killer (NK) cells, enhancing the body's natural capacity to destroy circulating cancer cells. Direct Anti-Angiogenesis: The active drug stops the creation of micro-vessels inside the bone marrow microenvironment by blocking vital chemical messengers, including Vascular Endothelial Growth Factor (VEGF), effectively cutting off the tumor's supply of oxygen and nutrients. 3. Administration and Dosing Guide Administration Route: Celomide 10mg is formulated strictly as an oral capsule. The capsule must be swallowed whole with water at the same time each day and must never be broken, split, crushed, chewed, or opened. Caregivers must avoid direct skin exposure to the powder contents of broken capsules. Cyclical Treatment Schedules: Dosing strategies are highly personalized according to the patient’s kidney health and blood tolerance. For instance, a common multiple myeloma cycle entails taking a 10mg capsule once daily for 21 consecutive days of a 28-day cycle, followed by a mandatory 7-day rest window to allow the bone marrow to recover. Food Affiliation: It can be taken consistently either with or without food. 4. Safety, Side Effects, and Monitoring Severe Bone Marrow Suppression: This medication frequently causes notable cytopenias, particularly severe neutropenia (profound depletion of white blood cells, heightening infection risks) and thrombocytopenia (low blood platelets, increasing the risk of bleeding and bruising). Regular baseline and periodic Complete Blood Counts (CBC) are mandatory. Thromboembolic Hazards: There is a significantly elevated risk of developing life-threatening Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), or arterial clots (stroke/myocardial infarction), especially when paired with corticosteroid therapies. Anticoagulant prophylaxis is commonly co-prescribed. Common Adverse Reactions: Patients commonly report fatigue, chronic diarrhea or constipation, localized skin rashes, muscle cramps, nausea, dizziness, headache, and peripheral edema (fluid retention in limbs). 5. Storage and Handling Specifications Climate Management: Store Celomide 10mg capsules below 30°C (86°F) in a dry, dark, climate-controlled space. Environmental Safeguards: Keep the capsules securely sealed within their original manufacturer bottle or blister packing to shield the sensitive active ingredients from high humidity, moisture, and direct UV light. Keep completely out of reach of children and pets. Prescription Medicine: Yes Clinical Disclaimer: This profile is compiled strictly for commercial educational research and international informational transparency. Celomide 10mg Capsule is a highly restricted, specialized oncology drug available exclusively under valid clinical prescription. It must be dispensed, handled, and managed solely under the direct guidance and supervision of a registered hematology-oncology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celomide 5mg Capsule Celomide 5mg Capsule contains Lenalidomide, a highly effective, small-molecule immunomodulatory agent (IMiD) with specialized anti-angiogenic and direct antineoplastic activities. Manufactured under exacting global standards by Celon Laboratories Ltd., this oral targeted therapy is recognized by oncologists internationally as an integral component in management protocols for complex bone marrow disorders and hematological malignancies. 1. Clinical Indications & Usage Multiple Myeloma (MM): Prescribed in combination with dexamethasone (and frequently integrated into advanced triplet therapies) for adult patients with relapsed or refractory multiple myeloma, or deployed as an independent post-transplant maintenance therapy to prolong progression-free survival. Myelodysplastic Syndromes (MDS): Indicated for patients suffering from transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with a cytogenetic abnormality known as a deletion 5q (del 5q) chromosomal defect. Mantle Cell Lymphoma (MCL): Authorized for adult patients with mantle cell lymphoma whose disease has returned or progressed following prior systemic lines of therapy (including bortezomib). 2. Mechanism of Action: How Celomide Works Immune Modulation: Celomide binds directly to Cereblon (CRBN), a substrate adapter within the intracellular E3 ubiquitin ligase enzyme complex. This binding induces the selective degradation of crucial lymphoid transcription proteins, which up-regulates the patient's native T-cells and Natural Killer (NK) cells, enhancing their ability to recognize and kill circulating cancer cells. Direct Tumor Apoptosis: It directly stalls the cell division cycle inside mutated plasma cells and lymphoma populations, inducing intracellular stress that forces abnormal cells into programmed cell death (apoptosis). 3. Administration and Dosing Guide Administration Route: Celomide 5mg is strictly an oral capsule formulation. The capsule must be swallowed whole with a full glass of water and should never be broken, crushed, split, chewed, or opened. Caregivers must avoid inhaling or coming into direct skin contact with the powder inside damaged capsules. Food Affiliation: It can be taken consistently at the same time each day, either with or without food. Cycle-Based Schedules: Treatment plans are highly specific to the clinical indication. For instance, in a standard multiple myeloma or lymphoma cycle, a 5mg dose may be taken once daily for 21 consecutive days of a 28-day cycle, followed by a mandatory 7-day rest window to allow blood levels to recover. 4. Safety, Side Effects, and Monitoring Severe Hematological Suppression: This medication frequently causes substantial bone marrow suppression. This can result in severe neutropenia (low infection-fighting white blood cells) and thrombocytopenia (low blood platelets, increasing the risk of bruising or bleeding). Regular, baseline, and monthly Complete Blood Counts (CBC) are mandatory. Thromboembolic Events: Patients have an increased risk of developing dangerous blood clots, including Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), as well as arterial events (myocardial infarction or stroke). Prophylactic blood thinners are routinely co-prescribed. Common Side Effects: Fatigue, chronic diarrhea or constipation, muscle cramps, nausea, localized skin rashes, headache, dizziness, peripheral edema (fluid swelling in lower limbs), and upper respiratory tract infections. 5. Storage and Handling Specifications Environmental Shields: Keep capsules sealed inside their original manufacturer packaging. Protect the bottles from high ambient humidity, excessive moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. Temperature Protocols: Store Celomide 5mg capsules at controlled room temperature between 15°C to 30°C (59°F to 86°F) in a dark, dry location. Prescription Medicine: Yes Clinical Disclaimer: This profile is compiled strictly for informational, educational, and international sourcing transparency. Celomide 5mg Capsule is a restricted, specialized oncology drug available exclusively under valid medical prescription. It must be managed, dispensed, and utilized solely under the direct guidance of a registered oncology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Product Profile: Celnalid 25mg Capsule Celnalid 25mg Capsule contains Lenalidomide, a premier small-molecule immunomodulatory drug (IMiD) that exerts direct anti-cancer, immune-modulating, and anti-angiogenic actions. Produced under exacting global quality parameters by Celon Laboratories Ltd., this higher-strength oral targeted therapy is an essential pillar in international hematology-oncology regimens for managing aggressive plasma cell and lymphoid malignancies. 1. Clinical Indications & Usage Multiple Myeloma (MM): Implemented in initial combination regimens or relapsed/refractory treatment lines alongside Dexamethasone or as part of highly effective triplet therapies. The 25mg strength serves as the standard starting dose for the loading phase of many 28-day multiple myeloma cycles. Mantle Cell Lymphoma (MCL): Prescribed for patients with mantle cell lymphoma whose disease has relapsed or progressed after undergoing at least one prior intensive systemic treatment. Follicular Lymphoma (FL): Deployed in combination with a rituximab regimen to treat adult patients with previously treated low-grade or slow-growing follicular lymphoma. Myelodysplastic Syndromes (MDS): While lower doses are often used for maintenance, the 25mg profile remains a vital clinical tool for specific high-burden hematological disorders, including transfusion-dependent anemia caused by low-to-intermediate-risk deletion 5q (del 5q) myelodysplastic abnormalities. 2. Mechanism of Action: How Celnalid Works Cereblon Binding & Degradation: The active drug binds directly to the Cereblon (CRBN) E3 ubiquitin ligase complex. This binding alters the structural affinity of the enzyme, forcing the selective degradation of specific lymphoid transcription proteins (IKZF1 and IKZF3). Immune System Amplification: By modifying these intracellular pathways, Celnalid triggers a powerful immune up-regulation. It directly boosts the proliferation and activation of the body's native T-cells and Natural Killer (NK) cells, vastly improving their capacity to identify, hunt, and destroy floating cancer cells. 3. Administration and Dosing Guide Administration Route: Celnalid 25mg is strictly an oral capsule formulation. The capsule must be swallowed whole with a glass of water at the same time each day. It must never be chewed, crushed, split, or opened. Caregivers should avoid direct skin contact with broken or damaged capsules. Food Dynamics: It can be taken safely with or without food. Cyclical Dosing Framework: For multiple myeloma and mantle cell lymphoma, the conventional starting schedule is 25 mg taken orally once daily on Days 1 through 21 of repeated 28-day treatment cycles, followed by a mandatory 7-day rest window (Days 22–28). Oncologists may adjust dosing dynamically based on regular laboratory tolerance feedback. 4. Safety, Side Effects, and Monitoring Severe Hematological Cytopenias: The primary risk is severe bone marrow suppression. This frequently presents as deep neutropenia (profound drop in white blood cells, spiking infection risks) and severe thrombocytopenia (low platelet counts, causing bruising or abnormal bleeding). Regular, baseline, and weekly Complete Blood Counts (CBC) are standard practice during early treatment cycles. Thromboembolic Risk: There is an escalated risk of developing life-threatening Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), or arterial clots (myocardial infarction or stroke), especially when combined with steroids. Prophylactic anticoagulation therapies are routinely co-prescribed. Common Adverse Reactions: Severe fatigue, chronic diarrhea or constipation, generalized pruritus (itching), skin rashes, muscle cramps, peripheral edema (fluid swelling in limbs), nausea, and dizziness. 5. Storage and Handling Specifications Climate Controls: Store Celnalid 25mg capsules below 30°C (86°F) in a dry, temperature-controlled medical storage location. Shielding Safeguards: Keep the capsules tightly sealed within their original manufacturer packaging. Protect the medication from prolonged exposure to high ambient humidity, ambient moisture, and direct UV light. Keep completely out of the reach of children and domestic pets. Prescription Medicine: Yes Clinical Disclaimer: This profile is compiled strictly for informational, educational, and international sourcing transparency. Celnalid 25mg Capsule is a highly restricted, specialized oncology drug available exclusively under valid medical prescription. It must be handled, dispensed, and managed under the direct supervision of a registered hematologist-oncologist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] 🌐 Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130